CVS: Spironolactone - Position Statement on MHRA Drug Safety Update
-
Due for review30 March 2018
-
Clinical support group
- Cardiovascular and Lipids
-
Conditions and indicators
Do you want to add this to your CPD record?
Did you find this page helpful?